| Metric | შპს ქრომოსი | შპს ტლ მედიკალ | შპს მედლაბ 2024 |
|---|---|---|---|
| Growth | |||
| Revenue | ₾1.8m | ₾1.8m | ₾1.8m |
| Revenue growth | — | — | — |
| Profitability | |||
| EBITDA | ₾525k | ₾218k | ₾582k |
| EBITDA margin | 28.5% | 12.3% | 33.0% |
| Net profit | ₾537k | ₾209k | ₾586k |
| Net margin | 29.1% | 11.8% | 33.2% |
| Balance sheet | |||
| Total assets | ₾2.2m | ₾2.3m | ₾1.3m |
| Total equity | ₾50k | ₾1.1m | ₾586k |
| ROE | 1067.0% | 18.7% | 100.0% |